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Abstract
Background: Identification of genes with ascending or descending monotonic expression patterns over time or
stages of stem cells is an important issue in time-series microarray data analysis. We propose a method named
Monotonic Feature Selector (MFSelector) based on a concept of total discriminating error (DEtotal) to identify
monotonic genes. MFSelector considers various time stages in stage order (i.e., Stage One vs. other stages, Stages
One and Two vs. remaining stages and so on) and computes DEtotal of each gene. MFSelector can successfully
identify genes with monotonic characteristics.
Results: We have demonstrated the effectiveness of MFSelector on two synthetic data sets and two stem cell
differentiation data sets: embryonic stem cell neurogenesis (ESCN) and embryonic stem cell vasculogenesis (ESCV)
data sets. We have also performed extensive quantitative comparisons of the three monotonic gene selection
approaches. Some of the monotonic marker genes such as OCT4, NANOG, BLBP, discovered from the ESCN dataset
exhibit consistent behavior with that reported in other studies. The role of monotonic genes found by MFSelector
in either stemness or differentiation is validated using information obtained from Gene Ontology analysis and
other literature. We justify and demonstrate that descending genes are involved in the proliferation or self-renewal
activity of stem cells, while ascending genes are involved in differentiation of stem cells into variant cell lineages.
Conclusions: We have developed a novel system, easy to use even with no pre-existing knowledge, to identify
gene sets with monotonic expression patterns in multi-stage as well as in time-series genomics matrices. The case
studies on ESCN and ESCV have helped to get a better understanding of stemness and differentiation. The novel
monotonic marker genes discovered from a data set are found to exhibit consistent behavior in another
independent data set, demonstrating the utility of the proposed method. The MFSelector R function and data sets
can be downloaded from: http://microarray.ym.edu.tw/tools/MFSelector/.
Background
In many biological experiments, we analyze regulation of
gene or protein expression over time and in some other
cases we examine how the expression pattern changes as
the grade/stage of a disease progresses, including over time.
These biomarkers are “Monotonic” because their pattern
ascends or descends with time (or stage/grade), important
in time-series studies (i.e., disease progression, stem cell
differentiation, aging and drug kinetics experiments) [1,2].
For example, HNF4a is a well-known factor promoting
stem cell hepatogenesis [3], and its levels increase with a
monotonic pattern during differentiation [4]. Genes in
such studies may exhibit a natural temporal ordering in
the samples, distinguishing them from others dealing with
issues like discriminating tumor from non-tumor cases. A
time series model generally shows that samples close in
time are more closely related. For example, the expression
of a stemness gene or microRNA should be more abundant
in stem cells and precursors than in fully differentiated and
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mature progenies. Here we identify those genes monotoni-
cally ascending or descending over a given period of time.
Many approaches are used to find differentially expressed
biomarkers from microarray data [5-8]. By statistical tests
and other computational methods, the two-class and
multi-class array data are usually analyzed focusing on the
class-specific signature genes (i.e., genes that are expressed
for one/some class(es) and unexpressed for the other/rest
of the class(es)). In order to identify differentially expressed
genes, many approaches adopt Student’s t-test for two-
class data, and few approaches adopt statistical tests such
as ANOVA F-test for multi-class data [9] or a nonpara-
metric rank-based statistical test such as Kruskal-Wallis
test [10] also for multi-class data [11-14]. However, distri-
bution-based and rank-based statistical tests may not be
appropriate because they find differentially expressed
genes, not monotonically ascending or descending genes.
Some methods to discover monotonic expression pat-
terns are correlation-based, where a seed feature or tem-
plate is chosen to find genes with good correlation. But the
choice of the template plays a critical role, and this is time-
consuming, requiring experienced bioinformaticians. In
addition, the Cuzick-test [15] can be used to discover a spe-
cific trend/pattern from microarray data. Also, the modified
M statistic test [16] can be used to detect monotonic trend
through a combination of the means ordering strategy and
a distribution-based statistical test. However, outliers affect
the monotonic trend there because of weighting used in the
Cuzick-test and the means ordering strategy used in the
modified M statistic test. Furthermore, the Cuzick-test does
not provide any information about the extent a gene
expression pattern is monotonic (i.e., the degree of “mono-
tonicity”) for genes with the same z-score/p-value. There-
fore, an approach without statistical assumptions and not
affected by outliers, and able to identify the degree of
monotonicity between genes with the same z-score/
p-value, is needed. Our method proposed herein, MFSelec-
tor (Monotonic Feature Selector) based on the total discri-
minating error (DEtotal), is quite effective in discovering
genes with monotonic attributes. It identifies gradually
increasing or decreasing genes irrespective of any heteroge-
neity in the array data. Furthermore, MFSelector, eliminates
the subjectivity required in seed/template selection and also
provides assessments of confidence (i.e., p-/q-value and
sample variance for discriminating error). This new
approach is user-friendly as we integrate our algorithm into
a simple R function. Users with no proficiency in program-
ming can generate a monotonic gene list and related scatter
plots.
Methods
Data Sets
All microarray data sets were downloaded from the
NCBI GEO public archive, generated in Affymetrix
Human Genome U133 Plus 2.0 platform with 54675
probe sets on chips. The raw data (CEL file) were nor-
malized by RMA algorithm using the ‘affy’ package of
the Bioconductor http://www.bioconductor.org [17] soft-
ware suite in the R Project for statistical Computing
http://www.r-project.org. See Materials S1 in Additional
file 1 for details.
Embryonic Stem Cell Neurogenesis data set (ESCN)
This data set contains 27 samples over five periods of
human embryonic development: three embryonic stem
cell (ESC) samples, three embryoid body (EB) samples,
six primitive ectoderm cell (PEL) samples, six neural
tube-like rosette cell samples, and nine post-natal neural
stem cell (NSC) samples.
Embryonic Stem Cell Vasculogenesis data set (ESCV)
In this data set, there are 13 samples over four periods of
human embryonic stem cell differentiation into human
mature (vascular) endothelial cells: three undifferentiated
embryonic stem cell (ESC) samples, three mesodermal
progenitor cell (MPC) samples, four embryoid body (EB)
samples, and three human mature vascular endothelial cell
(VEC) samples. The results and discussion of application
of MFSelector to this data set are exhibited in Materials
S1 (in Additional file 1).
Synthetic data sets
We generated two sets of synthetic data. These data sets
contain 50 samples each spread over five equal sized
stages. There is a set with descending trends (denoted
‘Des’) and a set with ascending trends (denoted ‘Asc’).
These synthetic data sets are named ‘s50_Asc’ and
‘s50_Des’, respectively. In addition, each data set has 120
genes which are classified into 9 types of monotonic genes
(or monotonic-like genes): ‘Good (distinct)’, ‘Good (close)’,
‘Slightly’, ‘Outliers (slight)’, ‘Outliers (severe)’, ‘Moderately’,
‘Severely’, ‘Partially ordered (far)’, and ‘Partially ordered
(close)’. There are 20 genes for each of ‘Slightly’, ‘Moder-
ately’, and ‘Severely’ types and 10 genes for each of ‘Good
(distinct)’, ‘Good (close)’, ‘Outliers (slight)’, ‘Outliers
(severe)’, ‘Partially ordered (far)’, and ‘Partially ordered
(close)’. If most of the samples follow a trend over time/
stages but only a few do not, we call those few samples as
outliers. In this study the number of outliers for the syn-
thetic data sets is restricted to less than 6% of total
samples.
Here we use genes with a monotonic ascending trend to
illustrate these nine types of genes used in the synthetic
data as shown in Figure 1. In this study, genes with a
monotonic ascending trend are those where the average
expression values of samples in Stage One are lower than
those of samples in Stage Two, the average expression
values of samples in Stage Two are lower than those of
samples in Stage Three, and so on. In the synthetic data
sets, ‘Good’ type genes have the strongest degree of mono-
tonicity followed in order with ‘Slightly’, ‘Moderately’, and
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‘Severely’ monotonic type genes. For ‘Good’ type genes,
there is no overlapping of samples between stages, and for
‘Severely’ type genes, the samples in one stage have sam-
ples that severely overlap the samples in the adjacent/
other stages. In addition, ‘Partially ordered’ type genes
indicate that the samples in four of the five stages form a
monotonic ascending trend, while the samples in the
remaining stage overlap the samples in other stages. ‘Out-
liers’ type genes denote that samples in the five stages
form a monotonic ascending trend, but some of the
samples in one of the five stages are slightly/significantly
away from the expression values of other samples in the
same stage.
The ‘Good’ category has two subcategories, ‘Good
(distinct)’ and ‘Good (close)’. ‘Good (distinct)’ genes
indicate they have the strongest monotonic ascending
trend and samples have distinct separation between
stages; while ‘Good (close)’ genes indicate they still have
the strongest monotonic trend but samples between
stages are close. ‘Partially ordered’ type genes are also
Figure 1 Scatter plots of nine types of monotonicity. Examples of each type of genes in the synthetic data set. (A) g1 (a ‘Good (distinct)’
type gene); (B) g18 (a ‘Good (close)’ type gene); (C) g21 (a ‘Slightly’ type gene); (D) g46 (a ‘Outliers (slight)’ type gene); (E) g53 (a ‘Outliers
(severe)’ type gene); (F) g61 (a ‘Moderately’ type gene); (G) g82 (a ‘Severely’ type gene); (H) g102 (a ‘Partially ordered (close)’ type gene); (I) g111
(a ‘Partially ordered (far)’ type gene).
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further separated into ‘Partially ordered (far)’, and
‘Partially ordered (close)’. The ‘Partially ordered (far)’
means that the samples in one of the stages are signifi-
cantly far from the monotonic trend in a gene expres-
sion profile while ‘Partially ordered (close)’ means that
the samples in one of the stages are close to the mono-
tonic trend but it is still out of monotonic order in the
gene expression profile. The genes of type ‘Outliers
(severe)’ represent genes where at most six percent of
the samples are relatively away from the monotonic
trend, and type ‘Outliers (slight)’ indicates that at most
six percent of the samples are slightly away from the
monotonic trend. The results on these synthetic data
sets by our proposed method (MFSelector) and other
two methods are presented in the Results section.
Monotonic Feature Selector (MFSelector)
In this study, we propose a novel tool, Monotonic Feature
Selector (MFSelector) which includes a novel index, called
DEtotal (total discriminating error), used to identify genes/
biomarkers with stronger monotonic features which may
bear a correlation to stem cell development. DEtotal does
not make any distributional assumption about the data.
MFSelector also provides the related statistical information
(p- and q- value) for each monotonic gene. Moreover, in
order to distinguish among monotonic genes with the
same DEtotal, MFSelector also offers an additional novel
index, called SVDE (sample variance for discriminating
error). Users can download MFSelector from the web site:
http://microarray.ym.edu.tw/tools/MFSelector/. Figure 2
depicts the processing steps involved in the computation
of DEtotal, p- and q- values, and SVDE.
Computation of discriminating error for each level of a
gene
Here we use several steps to examine genes with mono-
tonically ascending or descending profiles, which are dis-
tributed over N stages. For example, when a monotonic
gene has an ascending profile, first we assume samples in
Stage One have the lower expression values and samples
in other stages have higher expression values. We use a
sample in Stage One to draw a horizontal discriminating
line to determine how many samples in Stage One have
higher expression values than the discriminating line and
how many samples in other stages have lower expression
values than the discriminating line. The number of sam-
ples on the wrong side of the discriminating line is
referred to as “discriminating errors”. Distinguishing
Stage One from all other stages is called the “Level One”
process. In addition, since every sample in Stage One can
be used to draw a discriminating line, we select the dis-
criminating line with the smallest number of discriminat-
ing errors for this level. Note that, when more than one
discriminating line for Stage One have the same number
of discriminating errors, we can choose any one of the
lines; here we use the discriminating line corresponding
to the lowest sample number. Secondly, again for the
same gene, as a “Level Two” process, we assume samples
in Stages One and Two have lower expression patterns
than samples in other stages. Therefore, we use each
sample from Stages One and Two taken together to draw
a discriminating line and determine discriminating error
as in Level One. When more than one sample from
Stages One and Two together result in the same smallest
number of discriminating errors, we consider: (a) when
the samples are from the same stage, then we select the
line (hence the sample) corresponding to the lowest sam-
ple number; (b) when the samples are from different
stages, we give priority to the lowest sample number
from the highest stage, in this case, Stage Two. This
entire process is repeated N-1 times, each time adding
one stage (e.g., for the “Level Three” process the union of
Stages One, Two and Three versus all other stages; for
the “Level Four” process the union of Stages One, Two,
Three and Four against all other stages, and so on until
the “Level N-1”). The discriminating line is selected in
the same manner for each of the N-1 levels (in total, N-1
discriminating lines are considered for a gene). It is inter-
esting to note that, if the number of distinct discriminat-
ing lines is equal to N-1, the corresponding gene is more
likely to be a good monotonic gene.
Our outlier strategy is different from that used by
rank-based statistical tests (e.g., Cuzick-test), where an
outlier’s deviation in expression value influences its
rank, often adversely affecting the statistical calculation.
MFSelector does not count samples on the wrong side
of the discriminating line more than once. Suppose an
outlier adds a discriminating error in the Level M pro-
cess. This outlier is very likely to add a discriminating
error in later levels, i.e., “Level M+1” to “Level N-1”).
But we count the outlier’s discriminating error only
once at Level M. We compare the results for the
Cuzick-test and ours in the Results section.
For a monotonic gene with a descending profile, samples
in Stage One should have the higher expression values
than the samples in other stages. Thus, we can get the
“discriminating errors” for “Level One” process by drawing
a discriminating line through one of the samples in Stage
One to determine the number of samples in Stage One
that have lower expression values than the discriminating
line and the number of samples in other stages having
higher expression values than the discriminating line. As
with an ascending profile, this process is repeated N-1
times, though in this case, in descending direction. The
discriminating line for each level is also selected in the
same manner as that for the ascending case.
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Computation of total Discriminating Error (DEtotal) for a
gene
In order to evaluate monotonicity of a gene (e.g., genes
with weak or strong monotonic features), we use the sum
of its discriminating errors over all N-1 level processes
(total discriminating error) denoted by “DEtotal“. For
instance, when DEtotal=k, k discriminating errors exist
over N-1 level processes. Here, the smaller DEtotal of a
gene, the fewer the number of discriminating errors and
the stronger the monotonicity of the gene. DEtotal is an
evaluation index to determine monotonic genes. We sort
the DEtotal values for all genes in increasing order to
select genes with stronger monotonic features for multi-
stage and time-series array data. Note that, in this study
we separately consider the DEtotal for monotonically
ascending or descending cases. In addition, we also
develop another strategy using sample variance for discri-
minating error (SVDE) to further determine the gene
with stronger monotonic feature when several genes have
the same DEtotal value. This is explained later.
Calculating DEtotal for a gene: an illustration
We now demonstrate our algorithm using a synthetic
gene profile with five stages as shown in Figure 3. Sup-
pose in this case, this gene has an ascending nature. We
perform the following steps for this gene as mentioned
above.
First, for the “Level One” process, every sample in
Stage One is used to draw a discriminating line to deter-
mine its associated number of discriminating errors (the
Figure 2 MFSelector processing steps. For a gene, the illustration of discriminating error (DE) in each level, total discrimination error (DEtotal),
and two statistical analyses is shown in this figure.
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number of samples in Stage One that have higher
expression values than the discriminating line and the
number of samples in other stages having lower expres-
sion values than the discriminating line). In this case,
we obtain 7, 2, and 2 discriminating errors taking each
of three samples in order from Stage One to draw the
discriminating lines. For example, one sample from Stage
One and another sample from Stage Four are on the
wrong side of the discriminating line when considering
the 2nd sample in Stage One to draw the discriminating
line, resulting in two discriminating errors. In addition,
since two discriminating lines (i.e., corresponding to
the 2nd and 3rd samples) from Stage One have the same
number of discriminating errors, we choose the sample
with the lowest sample number (i.e., 2nd sample) and get
two discriminating errors in this level.
Second, for the “Level Two” process, every sample in
Stages One and Two is used to draw a discriminating line
to determine its associated number of discriminating errors.
In this level, we obtain 3, 3, 4, 0, 2, and 1 discriminating
Figure 3 A synthetic gene profile. Panels (A) to (D) illustrate the processes of determining discriminating lines and discriminating errors in
each stage sequentially. The DEtotal of this synthetic gene is three. The newly identified discriminating errors are marked by red circle and will
be counted in a specific stage. The previously identified discriminating errors are indicated by shaded background and will not be counted in a
specific stage.
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errors taking each of six samples in order from Stages One
and Two to draw the discriminating lines. Note that, to
compute the discriminating errors for the “Level Two” pro-
cess, we do not consider the samples which have already
caused discriminating errors in “Level One”. Such samples
are masked pink in Figure 3(B), one sample from Stage
One and another sample from Stage Four. The extent of
outliers may strongly influence results in other methods,
but in our method we consider “outliers” only once to con-
tribute to the discriminating errors and hence it allows us
to determine monotonicity without the results being
skewed by the position of “outliers”. This is why our
method has some advantage over other approaches. Finally,
we choose the sample with the lowest number of discrimi-
nating errors (i.e., the 4th sample from Stage One and Two)
and get no discriminating errors in this level.
Third, for the “Level Three” process, every sample in
Stages One, Two, and Three is used to draw a discrimi-
nating line to determine its associated number of discri-
minating errors. We get 3, 9, 10, 6, 8, 7, 2, 4, 5, 1, 3,
and 1 discriminating errors taking each of 12 samples in
order from Stage One to Stage Three. The 10th sample
is selected as the discriminating line because its discri-
minating error is the lowest, and it has the lowest sam-
ple number of the two Level Three samples with the
same discriminating error of one.
Similarly, the process is continued for the “Level
Four”. In this case we determine the 16th sample with
no discriminating error. Finally, we add up all discrimi-
nating errors for each selected discriminating line from
every level and get the DEtotal = 2 + 0 + 1 + 0 = 3.
Statistical analysis of monotonic genes
Computation of p-value and q-value
To assess the statistical significance of the DEtotal index
associated with the identified genes in ascending and
descending profiles, a permutation test has been per-
formed in Figure 2. Both unadjusted p-values and
adjusted q-values for multiple comparisons are com-
puted as in our previous studies [7,8]. Let G be the total
number of genes and S be the total number of sample
points. The procedure followed is summarized below.
Step 1. Given a gene expression matrix X (xgs is the
expression intensity of gene g in sample unit s; 1 ≤ g ≤
G, 1 ≤ s ≤ S) with class labels (ys, 1 ≤ s ≤ S), we com-
pute the DEtotal,g for ascending case and denotes it by ag
for notational simplicity. Similarly, for the descending
case also we compute DEtotal,g and denote it by dg.
Step 2. Randomly permute the class labels ys B times (500
times in this study). In the bth permutation (1 ≤ b ≤ B),
compute a(b)g and d
(b)
g for gene g using the gene expression
matrix X and the permuted labels y(b)s .
Step 3. The p-value of the observed DEtotal,g with
ascending characteristic, ag, for gene g is
p(ag) =
∑B
b=1
∑G
g′=1 (a
(b)
g′ ≤ ag)
G × B
(1)
where I(·) is an indicator function that takes the value
one when true and takes the value zero when false.
Similarly, the p-value of the observed DEtotal,g with des-
cending nature, dg, is
p(dg) =
∑B
b=1
∑G
g′=1 I(d
(b)
g′ ≤ dg)
G × B
(2)
Step 4. To account for the multiple tests being per-
formed for the G genes, q-values of the observed ag and
dg are calculated as
q(ag) =
∑B
b=1
∑G
g′=1 I(a
(b)
g′ ≤ ag)∑G
g′=1 I(ag′ ≤ ag) × B
(3)
and
q(dg) =
∑B
b=1
∑G
g′=1 I(d
(b)
g′ ≤ dg)∑G
g′=1 I(dg′ ≤ dg) × B
(4)
Computation of sample variance for discriminating error
(SVDE)
Statistical tests are unable to distinguish which genes with
the same level of statistical significance are better. Two
genes with the same DEtotal may exhibit different monoto-
nicities. Therefore, we develop SVDE to address the
degree of monotonicity of a gene. This can also help to
differentiate between genes with the same DEtotal value.
For example, in the ESCN data set, LOC100506013
and FAM60A are monotonically descending genes and
have the same DEtotal = 0 (shown in Figure 4). However,
the expressions of the samples of FAM60A from Stages
One to Four are tightly grouped (albeit not overlapped)
and of LOC100506013 from Stages One to Four are
highly distinguished, and only the expression values of
the samples from Stages Four and Five are somewhat
close. For these two genes with the same DEtotal,
LOC100506013 should have a higher degree of monoto-
nicity (Figure 4(A)) than FAM60A (Figure 4(B)).
In order to assess the degree of monotonicity (particu-
larly when more than one gene have the same DEtotal),
all samples for each of the genes are slightly altered in
expression values to examine whether the DEtotal of the
altered expression values has changed significantly or
not. To evaluate this, we propose an index, called Sam-
ple Variance for Discriminating Error (SVDE). We per-
turb a dataset and evaluate the extent of confidence on
the monotonicity properly by adding noise to all sam-
ples (as shown in Additional file 2: Fig. S1), and apply
the same method to the perturbed a dataset to calculate
the DEtotal of genes.
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To perturb a dataset with m samples and n genes, we
first compute the standard deviation si of each gene xi
and divide it by 10 to compute s’i. Next, we generate m
noise values from a normal distribution with mean
equal to 0 and standard deviation equal to s’i for each
gene. Finally, we add such a random noise to every
observed value of gene xi. The noise corrupted gene is
used to compute its discriminating errors for each level.
Let the resulting total discriminating error for this noisy
gene be DEtotal. We repeat this procedure in the same
manner M times (M = 100 in this study), and get M
new DEtotal values for each gene. We denote the new
DEtotal value as the DEi, i = 1, 2, ..., M. Next we com-
pute the variance of these DEi values with respect to
original DEtotal for this gene. We denote the original
DEtotal as DEorg. Hence for these new DEtotal values we
can calculate the variance as
SVDE =
1
M
M∑
i=1
(DEi − DEorg)2 (5)
The SVDE is a measure of how far the set of the new
DEtotal values are spread around the original DEtotal
(DEorg). If each DEi is equal to or close to DEorg, the
SVDE will be very small. Figure 4(A) shows how hard it
is to change the DEtotal of a highly confident monotonic
gene even after randomly altering the expression values
of all samples. The smaller the SVDE, the stronger the
monotonicity of the gene. Figure 4(B) depicts the mono-
tonic profile of another gene where DEtotal is equal to
zero, but the SVDE is high. The reason is that separa-
tion between adjacent stages for Stages One to Four is
not sufficiently distinct. Consequently, genes with a
smaller SVDE can be considered more strongly mono-
tonic than genes with a larger SVDE.
One may think that the time interval between observa-
tions should be given importance in defining any index
for finding such stemness markers. This is not so because
here our objective is to discover monotonic stemness
marker genes which are associated with stages of stem
cell differentiation. These stages are clinical stages which
depend on pathology/clinical phenotypes and are not
defined taking observations with arbitrary/equal time
interval, but the biological process here dictates the time
interval between observations. However, our method
would be equally applicable to other experimental sce-
nario where the researchers design experiments to take
observations with equal time interval for some scientific
reasons. It does not matter if the required time interval is
large or small.
Cuzick-test
In order to further validate the ability of our method to
identify monotonic genes, we have made a comparison
with the Cuzick-test [15], an extension of a Wilcoxon-type
statistical test for discovering specific patterns with pre-
designed trends, such as oscillation, step-wise patterns,
and in this case monotonicity. Here we use the Cuzick-
test to compute the Cuzick value (z-score) for the gene
expression data for each gene as follows. Let n be the total
Figure 4 Scatter plots of 1559280_a_at (LOC100506013) and 223038_s_at (FAM60A) of the ESCN data set. Each has a DEtotal equal
to zero.
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number of samples from all classes, ri be the rank of the i
th
sample determined by the order of its expression value
among all samples, N be the number of stages, and pi be
the proportion of samples from class i. Each stage has a
weight wk, k = 1,...,N. We associate a weight zi to a sample
i, zi = wj, if the i
th sample is from the jth stage. The Cuzick
statistic is computed as
Z =
T − E(T)√
Var(T)
(6)
where
T =
n∑
i=1
ziri (7)
Var(T) =
(
n2(n + 1)
12
)
·
⎛
⎝ N∑
i=1
z2i p
i −
⎡
⎣ N∑
j=1
zjpj
⎤
⎦
2⎞
⎠ (8)
E(T) =
⎛
⎝ n∑
j=1
j
⎞
⎠ ·
⎛
⎝ N∑
j=1
zjpj
⎞
⎠ (9)
To find ascending genes, we use wi = i, i = 1, ..., N; while
for descending genes, we use wi = N-i+1, i = 1, ..., N. The
Cuzick statistic above is obtained as a z-score, hence, we
can determine a p-value for each gene and identify
whether a gene is monotonic and the extent of its mono-
tonicity (a stronger monotonic gene with a smaller
p-value) by referring to the z-score table. In this study, we
compare the performance of the Cuzick-test approach and
our MFSelector approach (shown in the Results section).
The modified M statistic test
We have also performed a comparison with the modified M
statistic test [16]. The modified M statistic test (a distribu-
tion-based statistical test) is used to analyze dose-response
studies in microarray experiments and investigate a trend in
the response level expression with respect to doses in multi-
class array data. In order to effectively find monotonic
genes, the modified M statistic test adopts the means order-
ing strategy that considers the order restriction of mean
expressions (responses) regarding the increasing or decreas-
ing doses through K stages, respectively. The modified M
statistic test and several other statistical tests are further
integrated into an R package called IsoGene [18]. However,
the modified M statistic test is less effective because the
existence of outliers in a stage strongly influences the order
of mean responses (as shown in the Results section).
Functional annotation
After getting the list of monotonic genes, we can sort
them by DEtotal or p-value in ascending order to identify
those genes with stronger monotonic patterns, and
decide the threshold for the gene list based on monoto-
nicity. In addition, we further sort these monotonic
genes with the same DEtotal values according to their
associated SVDE. The resulting gene list is fed into the
web service tool DAVID Bioinformatics Resources
http://david.abcc.ncifcrf.gov/ to identify correspondingly
enriched biological processes by cross-referencing to the
gene ontology database http://www.geneontology.org/.
Results
Results on the ESCN data set by MFSelector
As mentioned in the Materials and Methods section, we
use two microarray data sets, i.e., embryonic stem cell
neurogenesis (ESCN) and embryonic stem cell vasculogen-
esis (ESCV), to demonstrate the effectiveness of our algo-
rithm in identifying monotonic genes during different
stages of stem cell differentiation. The results of applica-
tion of MFSelector to the ESCV data set are exhibited in
Materials S1 (in Additional file 1).
Figure S2 (in Additional file 3) reveals that principal
component analysis (PCA) based on 9,285 probe sets
(obtained using t-test, q<0.01) clearly distinguishes
embryonic stem cells (ESCs) from post-natal neural stem
cells (NSCs). It also shows that embryoid bodies (EB),
primitive ectoderm cells (PEL) and neural rosette cells
are differentiated along the neural lineage as evidenced
by moving toward post-natal neural stem cells. Figure S2
(in Additional file 3) also shows that the addition of basic
fibroblast growth factor (bFGF or FGF2) [19] does not
make dramatic transcriptome changes on either day 10
primitive ectoderm cells (d10 and d10+) or day 17 neural
rosette cells (d17 and d17+). So samples in d10 and d10+
are considered to belong to the same stage in this experi-
ment. Similarly, samples in d17 and d17+ are considered
to be in the same stage also.
By applying our algorithm for the ESCN data set, we
create gene lists for the ascending and descending nature
respectively and sort these genes by the DEtotal. Using
DEtotal <= 7 with the constraint p-value<1.0E-5 and with
N-1 distinct discriminating lines (here N = 5), we get 857
ascending and 1,117 descending monotonic genes. The
lists of these genes and correlated gene information are
shown in Table S1 (in Additional file 4; available from:
http://microarray.ym.edu.tw/tools/MFSelector/). Since
there are too many monotonic genes whose p-value is
less than 1.0E-5, we illustrate approximately one hundred
top ranked ascending and descending genes from Table
S1 (in Additional file 4) by using two heatmap visualiza-
tions in Figure 5. Figure 5(A) displays a heatmap of 107
ascending monotonic genes with DEtotal <= 3. Similarly,
the gene expressions of the top 144 descending mono-
tonic genes (DEtotal <= 3) are delineated in a heatmap in
Figure 5(B). In Figure 5, the x-axis represents samples in
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the five stages in stage order (the color label bar at the
top represents the stage label, i.e., from black to aqua),
the y-axis represents the set of genes in descending DEto-
tal order. The gene expression values change gradually
from the blue band (low expression values) into the red
band (high expression values) in Figure 5(A), and vice
versa in Figure 5(B), making the monotonicity easily dis-
cernible and obvious.
Biomarkers for a specific cell type exhibit high expres-
sion values when the stem cell is differentiated to this
cell at the later stage of differentiation. This is a kind of
stemness markers. Figure 6(A) depicts PNMA2, one of
the top three ascending monotonic genes with DEtotal =
0 for the ESCN data set. For PNMA2, the samples from
each stage are well distinguished from the samples from
other stages sequentially because there is no discrimi-
nating error for every level of the process. A preliminary
study indicates that PNMA2 (paraneoplastic antigen
MA2, formerly known as MA2) is homologous to a
recently cloned gene, MA1, which is a novel neuron-
and testis-specific protein, and is recognized by the
serum of patients with paraneoplastic neurological dis-
orders [20]. Another two of the top three ascending
monotonic genes (PCDH9 and NPAS3) also have
correlation with neuronal receptor and neurogenesis
[21,22]. Hence, the top three ascending monotonic
genes identified by MFSelector from the ESCN data set
are in fact reported to be related to neurogenesis. In
addition, MFSelector has also identified SOX1 (DEtotal =
4), a famous marker for neural lineage cells [23].
Similarly, there are another kind of stemness markers
which exhibit high expression at early stages of develop-
ment and are monotonically descending during embryo-
nic stem cell differentiation into the other cells/tissues
(here, NSCs in the ESCN data set and vascular endothe-
lial cells in the ESCV data set). Figure 6(B) displays
DNMT3B, one of the top 12 descending genes with
DEtotal = 0. Here, samples from all stages are also well
separated by discriminating lines for each level.
DNMT3B is associated with embryonic stem cell devel-
opment [24]. Some of other top 12 descending genes
are correlated with developmental pluripotency and are
usually expressed in undifferentiated pluripotent stem
cells (i.e., EPCAM and DPPA4) [25,26]. Thus, some of
these top descending monotonic genes may play impor-
tant roles in maintaining pluripotentiality. We shall
further discuss some well-known embryonic stem cell
related genes in Discussion section. Note that, we also
Figure 5 Heatmaps of the two monotonic gene sets of the ESCN data set. The x-axis represents samples in the five stages in stage order
(the color label bar at the top represents the stage label, i.e., from black to aqua), the y-axis represents the set of genes in descending DEtotal
order. The gene expression values change gradually from the blue band (low expression values) into the red band (high expression values) and
vice versa. (A) 107 genes with ascending profiles and their range of DEtotal are from zero to three; (B) 144 genes with descending profiles and
their range of DEtotal are from zero to three.
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identify some other previously unreported (or reported)
genes of unknown function (or related to some biologi-
cal function) with monotonic features.
In addition, we have checked one by one whether the
top monotonic genes with DEtotal <= 3 (136 descending
genes and 98 ascending genes with formal gene sym-
bols) in the ESCN dataset are reported in the literature
to be related to some stem cell characteristics, including
stemness, differentiation, reprogramming, or induced
pluripotent stem cell (iPS). Here we find that 54 (40%)
monotonically descending genes related to some stem
cell characteristics: stemness (44 genes), reprogramming
(6 genes), and iPS (4 genes). Thirty-four (25%) genes are
related to differentiation and some of them are related
to embryogenesis. We could regard some of identified
descending genes as stemness or embryo biomarkers.
On the other hand, 30 (31%) monotonically ascending
genes are found to be related to differentiation and
most of them are related to neurogenesis (e.g., glia,
nerve or other neural elements). We could also regard
some of identified ascending genes as biomarkers of spe-
cific cell types in the differentiated cells. Please see
Table S2 (in Additional file 5).
Furthermore, we have also checked one by one
whether the top monotonic genes with DEtotal <= 3 in
the ESCN dataset have a bi-stable profile with a signifi-
cant drop or rise in expression level between two suc-
cessive stages. We subjectively find that about 11 (11%)
ascending genes and 17 (12.5%) descending genes are
likely to have bi-stable switches. In the Table S2 (in
Additional file 5), we have discussed some of those
genes that are reported in the literature to be related to
some stem cell characteristics.
To differentiate genes with the same DEtotal, we provide
the SVDE value for each monotonic gene in Table S1 (in
Additional file 4). Figure 7 shows the gene expression
patterns of four ascending monotonic genes with the
same DEtotal/p-value (DEtotal = 1). These four genes are
distinguished by the SVDE values obtained by adding
noise to the expression value and repeating the process
100 times. Figure 7(A) reveals that SOX6, with SVDE =
0.37, is the most monotonic gene compared to the other
three genes in Figure 7, because its samples from differ-
ent stages are well separated, except for a single discrimi-
nating error for Stage Four. Thus the DEtotal is not easily
changed (i.e., a lower SVDE value) after adding noise to
each sample. Figure 7(B) shows that STMN4 with SVDE
= 0.91 is the second most monotonic gene, because the
expression values of two samples, one from Stage Three
and another from Stage Four, are very close. Therefore,
the number of misclassified samples (DEtotal) for STMN4
is changed more frequently than SOX6 during the 100
experiments after adding noise to each sample. Visual
inspection of the figures also suggests that STMN4 is the
next monotonic gene in the list of four. Figure 7(C) indi-
cates that ARID5B with SVDE = 2.03 is the third most
monotonic gene. This is indeed the case because every
two adjacent stages contain samples which have close
expression values. Finally, Figure 7(D) displays SCD5
with SVDE = 2.95 the least monotonic of the four genes.
A careful inspection of the figures also reveals the same
and this is so because samples from Stage Three and
Stage Four have expression values which are too close to
avoid misclassification during the SVDE process.
Comparison among three methods based on the ESCN
data
Since the Cuzick-test can find many monotonic genes
with the same rank, for preliminary comparison we have
decided to use ascending genes with rank up to 20 as
Figure 6 Scatter plots of 209598_at (PNMA2) and 220668_s_at (DNMT3B) of the ESCN data set with ascending and descending
profiles, respectively. (A) This is one of the top three ascending genes with DEtotal = 0; (B) This is one of the top twelve descending genes
with DEtotal = 0.
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determined by the Cuzick-test as an example. For
Cuzick-test, the number of genes selected with ranks
1~20 is 145. Then we use the top 145 monotonic
ascending genes identified by each of the other methods,
to find the number of common and unique identified
genes. From Table S3 (in Additional file 6), we find that
a large number of common genes (110 genes; 76%) are
discovered by the Cuzick-test and MFSelector. On the
other hand, a large number of unique genes are discov-
ered by the modified M statistic test (only 50 (34%)
common genes found with MFSelector and 54 (37%)
common genes found with Cuzick-test). The detail
results are shown in Table S3 and S4 (in Additional
files 6 and 7) for ascending and descending cases,
Figure 7 Scatter plots of the four monotonic genes of the ESCN data set, whose DEtotal values all are equal to one, illustrate the
sample variance for discriminating error (SVDE) by adding noise to each sample for 100 simulations. (A) 227498_at (SOX6) with
SVDE = 0.37 (1st); (B) 221236_s_at (STMN4) with SVDE = 0.91 (2nd); (C) 212614_at (ARID5B) with SVDE = 2.03 (3rd); (D) 224901_at (SCD5) with
SVDE = 2.95 (4th).
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respectively. These findings suggest that the perfor-
mances of the Cuzick-test and MFSelector are more
similar than the performances of the modified M statis-
tic test and MFSelector. However, there are some draw-
backs in the Cuzick-test, which will be revealed when
we further evaluate the three methods on the ESCN
data set and the synthetic data sets.
Comparison between results by the Cuzick-test and
MFSelector
For comparison with MFSelector, we have also applied
the Cuzick-test to the ESCN data set and the ESCV
data set, and determined the trends of the gene expres-
sion profiles. For illustration we have used only the
ESCN data set. The results demonstrate several superior
characteristics of MFSelector.
First, although the Cuzick-test can identify monotonic
genes, the Cuzick-test results contain some non-monotonic
genes (false positives) at or near the top of the gene lists.
Figure S3 (in Additional file 8) shows four genes identified
by the Cuzick-test as strong monotonic genes in terms of
z-score/p-value because only samples from one stage
(Stage Two) are out of the monotonic trend. Figure S3(A)
and (B) (in Additional file 8) display two genes with only
roughly ascending features as a result of the deviation from
the trend in the expressions of samples from Stage Two.
Figure S3(C) and (D) (in Additional file 8) display two
other genes with only roughly descending features as a
result of the deviation from the trend in the expressions of
samples also from Stage Two. Note that, MFSelector dis-
cards most of this kind of genes with a partial monotonic
trend (even though those genes have small DEtotal values)
by examining whether we can determine their N-1 distinct
discriminating lines.
Second, MFSelector uses SVDE to further determine
different levels of monotonicity of genes with the same
DEtotal values (p-values). Actually, many monotonic
genes ranked by the Cuzick-test have the same p-value.
For example, all of those genes with DEtotal = 0 always
belong to the Cuzick-test top level. Figures S4(A) and
(B) (in Additional file 9) show two genes with DEtotal =
0 that should have different levels of monotonicity
based on their respective SVDE values. Similarly, Figs.
S4(C) and (D) (in Additional file 9) also indicate differ-
ent monotonicity under MFSelector SVDE analysis for
two other genes which have the same DEtotal values
(here DEtotal = 2) and both are ranked 10
th in the list
generated by the Cuzick-test.
In addition, the Cusick-test may assign a low rank to a
highly monotonic gene that contains some outlier sam-
ples which in fact do not adversely affect monotonicity.
Figure S5(B) (in Additional file 10) shows that the gene
expression value for ZNF302 is 164th in the list generated
by MFSelector, but is 105th (in fact, its effective rank is
1279 because there are at least 1278 genes before the
gene in the ranked list) in the list generated by the
Cuzick-test because two samples from Stage One and
Four, respectively, are significantly distant from its stage
(they totally cross all samples of Stage Two and Three in
expression value). This situation arises because this
gene’s ranking is significantly affected by the weight
assigned to the anomalous expression value for these
samples from Stage One and Four, causing the poor
ranking for this gene under the Cuzick-test. Figure S5(A)
(in Additional file 10) also shows the same characteristic
influenced by outlier samples. On the other hand, the
Cusick-test may also give a high rank to a gene which is
insufficiently monotonic as a result of too much overlap-
ping, where the lack of monotonicity is quite clear. For
example, those monotonic genes in Figs. S6 and S7 (in
Additional files 11 and 12) have too much overlapping
among stages.
Comparison between results by the modified M statistic
test and MFSelector
By applying the modified M statistic test, we create two
gene lists, one for the ascending nature and the other for
the descending nature respectively, and sort these genes
by their corresponding M values. We illustrate only the
top hundred ranked ascending and descending genes by
using two heatmaps in Figs. S8 and S9 (in Additional files
13 and 14). Figure S8(A) (in Additional files 13) displays
the heatmap of one hundred ascending monotonic genes
produced by MFSelector and Fig. S8(B) (in Additional
files 13) displays the same produced by the modified M
statistic test. Similarly, the gene expressions of the top
hundred descending monotonic genes chosen by MFSe-
lector and the modified M statistic test are delineated in
heatmaps in Figs. S9(A) and (B) (in Additional files 14),
respectively. Note that, genes chosen from the top hun-
dred are further clustered using hierarchical clustering
with the average linkage strategy. It is evident from the
yellow rectangular area on the heatmaps created from
the gene lists (Figs. S8(B) and S9(B)), the genes found by
the modified M selector method are not monotonic. This
is a consequence of the existence of outliers in a stage
(expressed by few different colors in a stage) satisfying
the means ordering constraint. On the other hand, the
genes found by MFSelector actually have monotonic
trend (Figs. S8(A) and S9(A)).
Results on the synthetic data
Nine pseudo genes are chosen randomly from the 9
types of monotonic genes as shown in Figure 1. We also
use synthetic data sets to perform extensive compari-
sons, including quantitative and qualitative evaluations,
between MFSelector, the Cuzick-test, and the modified
M statistic test.
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Comparison among three methods based on the synthetic
data
In the ideal ranking, the top 60 pseudo genes should
belong to the type ‘Good (distinct/close)’ (20 genes),
‘Slightly’ (20 genes), and ‘Outliers (slight/severe)’ (20
genes), and that is what MFSelector does. The results
using the Cuzick-test are the approximately the same as
that by MFSelector, but the modified M statistic test
always selects about fifteen percent of genes in the type
‘Partially ordered’ which are worse cases and are out of
monotonic trend (as shown in Additional files 15 and 16:
Table S5 and S6). Nevertheless, the Cuzick-test and the
modified M statistic test are seriously affected by the varia-
tion in the nature of outliers such as “slight” versus
“severe” and the nature of partially ordered trends such as
“far” versus “close”. We think that both ‘Outliers’ type
genes, slight or severe, should have similar monotonic
trends. These outlier samples should not influence the
extent of monotonic trends. Similarly, in the ‘Partially
ordered’ type genes, no matter how significantly far the
samples in one of the stages are from the monotonic trend
in a gene expression profile, most of those genes should
not influence the degree of monotonicity. In addition, as
mentioned earlier, MFSelector discards most of this kind
of genes with a partial monotonic trend (even though
those genes have a small DEtotal values) by examining the
number of distinct discriminating lines. Therefore, genes
having slight/severe outliers or having partially ordered
patterns with the level ‘far’ or ‘close’ should be given the
similar significance/rank. For the synthetic data set, we
find that the ranks of the pseudo genes g46 (with slight
outlier characteristics) and g53 (with severe outlier charac-
teristics) discovered by MFSelector are not different (simi-
lar DEtotal value) but their ranks are significantly different
for the Cuzick-test and the modified M statistic test. The
ranks of the pseudo genes g102 (with a close partially
ordered stage) and g111 (with a far partially ordered stage)
identified by MFSelector are also not different (same DEto-
tal value) but the ranks suggested by the Cuzick-test and
the modified M statistic test are significantly different (as
shown in Figure 1(D), (E), (H), and 1(I) and Additional
file 15: Table S5).
Discussion
Biological relevance of other monotonic genes
Expressions of monotonic genes in different stages of
cell lineage are closely related to the function of specific
cell stage. Monotonicity of genes over stages is a good
rationale to identify biomarkers responsible for differen-
tiation of stem or precursor cells. For example, biomar-
kers for stemness exhibit high expression at early stages
and those are responsible for maintaining proliferation
and self-renewal activities. By contrast, biomarkers of
specific cell types exhibit high expression in later stages
after differentiation. And those genes also contribute to
the specific phenotype and function of differentiated
cells such as development of neural system which is
mentioned earlier.
Among the top ascending and descending monotonic
genes for the ESCN data set (shown in Additional file 4:
Table S1), we have found many well-known and annotated
marker genes proven and reported in previous studies. For
example, POU5F1 (OCT4), NANOG, and BLBP (FABP7)
(shown in Figures 8(A), (B) and 8(C), respectively) have
been identified as important marker genes (with the same
monotonic trends as observed in our study) in a microar-
ray time series analysis (a neurogenesis experiment from
day 0 to day 8) and further validated using RT-PCR [1].
POU5F1 (DEtotal = 2, number 39 in our list of descending
monotonic genes) is a well-known transcription factor for
maintaining and introducing stemness into embryonic
stem cells [1]. POU5F1 is also important for pluripotency
of embryonic stem cells [27]. NANOG (DEtotal = 4), is a
well-known transcription factor critically involved with
self-renewal of undifferentiated embryonic stem cells, and
BLBP (FABP7; DEtotal = 3) is a neuroepithelial progenitor
marker [1]. Furthermore, as reported earlier, BLBP is
always expressed during development in radial glia by the
activation of Notch receptors [28]. The expression of
BLBP is usually induced in neural progenitor cells via
Notch-1 activation [29]. Note that, in the previous study
authors have also reported another important gene, HES5
with some ascending monotonic characteristics. This is a
neuroepithelial progenitor marker [1] that mainly regu-
lates brain development process [30]. It is interesting to
observe that, while in the previous study, HES5 has been
characterized as a monotonic ascending gene by their
microarray data analysis, but in our study, Figure 8(D)
clearly shows that HES5 expression for stages 1-4 is up-
regulated and it is down-regulated for stage 5. Our finding
is consistent with that of the previous study [1], which
suggests that this gene is usually expressed in the rosette
stage (about day 8) and stage 5 is beyond day 8. Conse-
quently, in their RT-PCR experiment (until day 20), the
same up- and down-regulated variance in expression pat-
terns as shown in Figure 8(D) can be observed. While in
our study, MFSelector does not define such genes with
partial monotonic characteristics as good monotonic
genes. For HES5 it has a very high DEtotal = 15. In future
studies we may consider redefining DE values to include
partial monotonicity.
Another research [31] has also reported a gene list
comprised of known ESC-specific genes and some new
candidates (such as DNMT3B, LIN28A, BTF3 and ERH)
that can serve as markers for human embryonic stem
cells and may also contribute to the stemness pheno-
type. Of particular interest in that study is the strong
monotonic descending pattern of DNMT3B (DEtotal = 0)
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in our study during embryonic stem cell differentiation.
LIN28A is without N-1 distinct discriminating lines
because its expression is tightly grouping from Stage
One to Stage Three. It has a small number of discrimi-
nating errors (DEtotal = 4) though. Additional transcrip-
tion factors that were also highly expressed in human
embryonic stem cells include BTF3 and ERH. These
genes are marker genes for embryonic stem cell, which
show high expressions only in human embryonic stem
cells [31]. We depict the expression profile of these four
genes in the ESCN data set in Fig. S10 (in Additional
file 17). These scatter plots (as shown in Figs. S10(A),
(B) and (C)) fit within the scenario for embryonic stem
cell development explained by that study [31]. However,
the expression profile of ERH over different stage is not
clearly separated and is not monotonically descending
during the neurogenesis process (as shown in Fig. S10
(D)). We make a hypothesis that ERH does not clearly
exhibit monotonic expression during neurogenesis even
though it is an embryonic stem cell specific marker
Figure 8 Scatter plots of the four genes of the ESCN data set reported in the previous study [1]. (A) 208286_x_at (OCT4); (B) 220184_at
(NANOG); (C) 205029_s_at (BLBP); (D) 239230_at (HES5).
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gene. This new biomarker needs to be surveyed and
studied further both in wet- and dry- laboratory
experiments.
Biological processes involved in monotonic genes
The genes expressed in an early stage of stem cells or in
undifferentiated cells (or precursor cells) of stem cells
are often regarded as stem cell biomarkers, which are
thought to maintain the pluripotency of embryonic stem
cells. Based on the concept of pluripotency, cell growth
or proliferation and the self-renewal activity are the
most representative characteristics of stem cells which
are known to be sustained by multiple genes in both
stem cells and precursor cells [32]. Differentiation of
stem cells or precursor cells is accompanied by the loss
of pluripotency, which suggests that the expression of
stemness related genes will decrease as well. This pro-
vides a rationale for why those genes should be included
in the descending gene list generated by MFSelector.
Logically, the differentiation program of stem cells and
precursor cells is not only driven by gene regulation but
also manipulated by the circumstances of differentiation
[33]. Combination of multiple stimulations in distinct
circumstances provides the specific niche for differen-
tiating into certain cell lineage, which is triggered by
growth factors, transcription factors, and the specific
cell surface receptors. Different growth factors or tran-
scription factors are accompanied by different signals
for the activation of specific functional genes, which are
responsible for the generation of specific cell lineage.
Therefore, we believe that those functional proteins
related to the specialized cell type, structures, and func-
tions will be involved in the ascending gene list gener-
ated by MFSelector.
To validate our inferences, we corroborate the biologi-
cal processes for those monotonic genes identified from
the two data sets by Gene Ontology analysis on the
DAVID web tool http://david.abcc.ncifcrf.gov/. This
helps us find distinct genes expressed in certain organo-
genesis with different processes.
For the ESCN data set, the top 857 ascending mono-
tonic genes (DEtotal = 0~7) found by MFSelector are
subjected to Gene Ontology analysis. Some of the biolo-
gical processes those genes are involved in are neuron
differentiation (41 genes, p-value = 8.1E-9), regulation of
neurogenesis (23 genes, p-value = 3.5E-8), regulation of
nervous system development (24 genes, p-value = 1.2E-
7), regulation of neuron differentiation (19 genes,
p-value = 4.6E-7), neuron development (31 genes,
p-value = 1.2E-6), neuron projection development (24
genes, p-value = 1.7E-5), cell morphogenesis involved in
neuron differentiation (21 genes, p-value = 2.5E-5), axo-
nogenesis (20 genes, p-value = 2.6E-5), neuron projec-
tion morphogenesis (21 genes, p-value = 3.2E-5), and
regulation of axonogenesis (11 genes, p-value = 1.7E-5).
These biological processes very likely play important
roles in differentiation of ESC neurogenesis and the
development of the organs or the tissues of the nervous
system. There are other ascending genes involved in
neurotransmission, such as regulation of axon extension
(7 genes, p-value = 3.5E-5), axon guidance (14 genes, p-
value = 5.8E-5), transmission of nerve impulse (26
genes, p-value = 3.2E-4), and neuron migration (9 genes,
p-value = 1.3E-3). These monotonic genes directly indi-
cate their importance during the development of the
nervous system and the process of neurogenesis.
Similarly, some of the top 1,117 descending mono-
tonic genes (DEtotal = 0~7) found by MFSelector are
involved in basic DNA/RNA biological processes, such
as translation (42 genes, p-value = 4.3E-9), RNA proces-
sing (57 genes, p-value = 7.8E-9), ribosome biogenesis
(23 genes, p-value = 2.4E-8), ribonucleoprotein complex
biogenesis (28 genes, p-value = 3.8E-8), rRNA proces-
sing (19 genes, p-value = 1.3E-7), and ncRNA metabolic
process (29 genes, p-value = 1.8E-6). According to the
common understanding about the characteristics of
undifferentiated or early stage stem cells, basic cellular
processes are crucial for maintaining the capacity of
self-renewal and proliferation. In addition, these mono-
tonic genes may be responsible for the basic metabo-
lisms and the stability of chromosome structures in
cells. Proliferation of cells must undergo the process of
cell cycle, and genes involved in the mechanism of cell
cycle are able to imply the progress of proliferation. In
conformity with this, we notice that genes for M phase
(32 genes, p-value = 9.3E-5), DNA replication (22 genes,
p-value = 1.4E-4), M phase of mitotic cell cycle (23
genes, p-value = 5.3E-4), mitotic cell cycle (32 genes,
p-value = 7.3E-4), nuclear division (22 genes, p-value =
1.0E-3), mitosis (22 genes, p-value = 1.0E-3), cell cycle
process (43 genes, p-value = 1.1E-3), and cell cycle
phase (34 genes, p-value = 1.2E-3) are in the descending
monotonic list. This evidence suggests that the stem cell
features in the early stage exist during neurogenesis.
Conclusions
We have developed a novel and robust scheme to identify
genes with monotonic patterns in multi-stage as well as
in time-series genomic data. Our method is based on a
concept of total discriminating error practically without
requiring any assumption. Using our proposed scheme
we have been able to reveal genes with gradually increas-
ing or decreasing expression patterns during stem cell
differentiation. Some of these genes are known stemness
genes (such as POU5F1 (Oct4)), while many other genes
have not been linked to stem cell neurogenesis or vascu-
logenesis before. In the ESCN and ESCV data sets mono-
tonic features could be found even from heterogeneous
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gene expression profiles. In addition, we have used
monotonic markers discovered from one data set to ana-
lyze another data set and obtained very interesting
results. An R package implementing our algorithm and
data sets can be found at: http://microarray.ym.edu.tw/
tools/MFSelector/.
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ESCV data set analyzed by principal component analysis.
Additional file 4: Table S1. The lists of monotonic genes and correlated
gene information of the ESCN and ESCV data sets.
Additional file 5: Table S2. Details for the top monotonic genes (DEtotal
<= 3) identified by MFSelector along with information from the literature
in support of the facts that those genes are related to some stem cell
characteristics, including stemness, differentiation, reprogramming or
induced pluripotent stem cells.
Additional file 6: Table S3. The lists of the number of common or
unique genes from the monotonic ascending gene set (the top 145
genes with ascending profiles) of the ESCN data set identified by
MFSelector, the Cuzick-test, and the modified M statistic test.
Additional file 7: Table S4. The lists of the number of common or
unique genes from the monotonic descending gene set (the top 163
genes with descending profiles) of the ESCN data set identified by
MFSelector, the Cuzick-test, and the modified M statistic test.
Additional file 8: Figure S3. Scatter plots of the four false positive
monotonic genes identified by the Cuzick-test from the ESCN data set.
(A) 200794_x_at (DAZAP2); (B) 229824_at (SHC3); (C) 206424_at (CYP26A1);
(D) 209122_at (PLIN2).
Additional file 9: Figure S4. Scatter plots of the four monotonic genes
with the same DEtotal values but different SVDE values identified from the
ESCN data set. (A) 1559280_a_at (LOC100506013); (B) 223000_s_at (F11R);
(C) 230896_at (BEND4); (D) 202234_s_at (SLC16A1).
Additional file 10: Figure S5. Scatter plots of the two monotonic genes
for the ESCN data set ranked low by the Cuzick-test but high by
MFSelector. (A) 202668_at (EFNB2); (B) 228393_s_at (ZNF302).
Additional file 11: Figure S6. Scatter plots of the four ascending
monotonic genes from the ESCN data set ranked high by the Cuzick-test
but low by MFSelector. (A) 225717_at (KIAA1715); (B) 226907_at
(PPP1R14C); (C) 229126_at (TMEM19); (D) 244040_at (KCNN3).
Additional file 12: Figure S7. Scatter plots of the four descending
monotonic genes from the ESCN data set ranked high by the Cuzick-test
but low by MFSelector. (A) 204765_at (ARHGEF5); (B) 201930_at (MCM6);
(C) 219786_at (MTL5); (D) 225359_at (DNAJC19).
Additional file 13: Figure S8. Heatmaps of the monotonic ascending
gene set (the top 100 genes with ascending profiles) of the ESCN data
set identified by MFSelector and the modified M statistic test,
respectively. (A) The top hundred monotonic ascending gene set chosen
by MFSelector; (B) The top hundred ascending gene set chosen by the
modified M statistic test.
Additional file 14: Figure S9. Heatmaps of the monotonic descending
gene set (the top 100 genes with descending profiles) of the ESCN data
set identified by MFSelector and the modified M statistic test,
respectively. (A) The top hundred monotonic descending gene set
chosen by MFSelector; (B) The top hundred descending gene set chosen
by the modified M statistic test.
Additional file 15: Table S5. The lists of the ranks of monotonic genes
for the synthetic data sets identified by MFSelector, the Cuzick-test, and
the modified M statistic test.
Additional file 16: Table S6. The list of the number of top genes
identified by MFSelector, the Cuzick-test, and the modified M statistic
test, in each type of monotonic genes of the synthetic data sets.
Additional file 17: Figure S10. Scatter plots of the four genes of the
ESCN data set reported in the previous study[31] (A) 220668_s_at
(DNMT3B); (B) 219823_at (LIN28A); (C) 214800_x_at (BTF3); (D) 200043_at
(ERH).
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